- Settembre 2024

Patel BK, Carnahan MB, Northfelt D, et al.

Prospective study of supplemental screening with contrast-enhanced mammography in women with elevated risk of breast cancer: results of the prevalence round

J Clin Oncol 2024 Jul 26:JCO2202819. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract | Scarica ppt

---

Rastogi P, Bandos H, Lucas PC, et al.

Utility of the 70-Gene MammaPrint assay for prediction of benefit from extended letrozole therapy in the NRG Oncology/NSABP B-42 trial

J Clin Oncol 2024 Jul 24:JCO2301995. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract | Scarica ppt

---

Di Meglio A, Havas J, Pagliuca M, et al.

A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance two years later

Ann Oncol 2024 Aug 2:S0923-7534(24)01517-5. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract | Scarica ppt

---

de Boniface J, Appelgren M, Szulkin R, et al.

Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial

Lancet Oncol 2024;25(9):1222-1230

Simonpietro Marrocco Settembre 2024

Leggi abstract | Scarica ppt

---

Williams LJ, Kunkler IH, Taylor KJ, et al.

Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial

Lancet Oncol 2024;25(9):1213-1221

Simonpietro Marrocco Settembre 2024

Leggi abstract | Scarica ppt

---

Giannakeas V, Lim DW, Narod SA

Bilateral mastectomy and breast cancer mortality

JAMA Oncol 2024 Jul 25:e242212. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Massa D, Vernieri C, Nicolè L, et al.

Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer

J Natl Cancer Inst 2024 Jul 31:djae178. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Wong JS, Uno H, Tramontano AC, et al.

Hypofractionated vs conventionally fractionated postmastectomy radiation after implant-based reconstruction: a randomized clinical trial

JAMA Oncol 2024 Aug 8:e242652. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

O’Regan RM, Zhang Y, Fleming GF, et al.

Breast cancer index in premenopausal women with early-stage hormone receptor-positive breast cancer

JAMA Oncol 2024 Aug 15:e243044. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Poggio F, Blondeaux E, Tagliamento M, et al.

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

ESMO Open 2024;9(8):103650

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Chapman JW, Bayani J, SenGupta S, et al.

Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole

J Clin Oncol 2024;42(24):2887-2898

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Zuo W, Wang Z, Qian J, et al.

QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: a multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial

Br J Cancer 2024;131(4):668-675

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Dent RA, Kim SB, Oliveira M, et al.

Ipatasertib plus paclitaxel for patients with PIK3CA/AKT1/PTEN-altered locally advanced unresectable or metastatic triple-negative breast cancer in the IPATunity130 Phase III trial

Clin Cancer Res 2024 Jul 26. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Schick A, Hardy S, Strawderman M, et al.

Impact of systemic disease on CNS disease control after stereotactic radiosurgery to breast cancer brain metastases (the SYBRA study)

NPJ Breast Cancer 2024;10(1):69

Simonpietro Marrocco Settembre 2024

Leggi abstract

---

Bardia A, Cortes J, Bidard FC, et al.

Elacestrant in ER+, HER2- MBC with ESR1-mutated tumors: subgroup analyses from the phase III EMERALD trial by prior duration of endocrine therapy plus CDK4/6 Inhibitor and in clinical subgroups

Clin Cancer Res 2024 Aug 1. Epub ahead of print

Simonpietro Marrocco Settembre 2024

Leggi abstract

---